Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)

被引：0

作者：

Juan P. Horcajada

Rebeca Aldonza

Mónica Real

Silvia Castañeda-Espinosa

Elena Sendra

Joan Gomez-Junyent

Inmaculada López-Montesinos

Silvia Gómez-Zorrilla

Silvia Briansó

Montserrat Duran-Taberna

Andrés Fernández

Cristina Tarragó

Teresa Auguet-Quintillá

机构：

[1] Universitat Pompeu Fabra (UPF),Department of Infectious Diseases, Hospital del Mar. IMIM, Passeig Marítim 25, 08003 Barcelona, Spain

[2] Instituto de Salud Carlos III,CIBERINFEC, CIBER of Infectious Diseases

[3] Clinical Development Lead,Service of the Internal Medicine

[4] Hospital Universitari de Tarragona Joan XXIII,Internal Medicine Service

[5] Universitat Rovira i Virgili,undefined

[6] IISPV,undefined

[7] Hospital Sant Pau i Santa Tecla,undefined

[8] Advanced Biotherapeutics Director,undefined

[9] R&D Project Lead,undefined

[10] GEMMAIR research group Institut d’Investigació Sanitària Pere Virgili (IISPV),undefined

来源：

Pneumonia | / 16卷

关键词：

Favipiravir; COVID-19; Pneumonia; Randomized clinical trial;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

共 50 条

[1] Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)
Horcajada, Juan P.
Aldonza, Rebeca
Real, Monica
Castaneda-Espinosa, Silvia
Sendra, Elena
Gomez-Junyent, Joan
Lopez-Montesinos, Inmaculada
Gomez-Zorrilla, Silvia
Brianso, Silvia
Duran-Taberna, Montserrat
Fernandez, Andres
Tarrago, Cristina
Auguet-Quintilla, Teresa
PNEUMONIA, 2024, 16 (01)
[2] Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
Piemonti, Lorenzo
Landoni, Giovanni
Voza, Antonio
Puoti, Massimo
Gentile, Ivan
Coppola, Nicola
Nava, Stefano
Mattei, Alessia
Marinangeli, Franco
Marchetti, Giulia
Bonfanti, Paolo
Mastroianni, Claudio Maria
Bassetti, Matteo
Crisafulli, Ernesto
Grossi, Paolo Antonio
Zangrillo, Alberto
Desai, Antonio
Merli, Marco
Foggia, Maria
Carpano, Marco
Schiavoni, Lorenzo
Monforte, Antonella D'Arminio
Bisi, Luca
Russo, Gianluca
Busti, Fabiana
Rovelli, Cristina
Perrotta, Elisabetta
Goisis, Giovanni
Gavioli, Elizabeth M.
Toya, Sophie
De Pizzol, Maria
Mantelli, Flavio
Allegretti, Marcello
Minnella, Enrico Maria
INFECTIOUS DISEASES AND THERAPY, 2023, 12 (10) : 2437 - 2456
[3] Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
Lorenzo Piemonti
Giovanni Landoni
Antonio Voza
Massimo Puoti
Ivan Gentile
Nicola Coppola
Stefano Nava
Alessia Mattei
Franco Marinangeli
Giulia Marchetti
Paolo Bonfanti
Claudio Maria Mastroianni
Matteo Bassetti
Ernesto Crisafulli
Paolo Antonio Grossi
Alberto Zangrillo
Antonio Desai
Marco Merli
Maria Foggia
Marco Carpano
Lorenzo Schiavoni
Antonella D’Arminio Monforte
Luca Bisi
Gianluca Russo
Fabiana Busti
Cristina Rovelli
Elisabetta Perrotta
Giovanni Goisis
Elizabeth M. Gavioli
Sophie Toya
Maria De Pizzol
Flavio Mantelli
Marcello Allegretti
Enrico Maria Minnella
Infectious Diseases and Therapy, 2023, 12 : 2437 - 2456
[4] Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial
Bosaeed, Mohammad
Alharbi, Ahmad
Mahmoud, Ebrahim
Alrehily, Sanaa
Bahlaq, Mohannad
Gaifer, Zied
Alturkistani, Hanan
Alhagan, Khaled
Alshahrani, Saad
Tolbah, Ali
Musattat, Abrar
Alanazi, Maha
Jaha, Raniah
Sultana, Khizra
Alqahtani, Hajar
Al Aamer, Kholoud
Jaser, Saud
Alsaedy, Abdulrahman
Ahmad, Ayoub
Abalkhail, Mohammed
AlJohani, Sameera
Al Jeraisy, Majed
Almaziad, Sultan
Albaalharith, Nahlah
Alabdulkareem, Khaled
Alshowair, Abdulmajeed
Alharbi, Naif Khalaf
Alrabiah, Fahad
Alshamrani, Majid
Aldibasi, Omar
Alaskar, Ahmed
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (04) : 602 - 608
[5] A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of a Nutritional Supplement (ImmuActiveTM) for COVID-19 Patients
Majeed, Muhammed
Nagabhushanam, Kalyanam
Shah, Kalpesh
Mundkur, Lakshmi
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
[6] Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
Bazdyrev, Evgeny
Panova, Maria
Brachs, Maria
Smolyarchuk, Elena
Tsygankova, Daria
Gofman, Liudmila
Abdyusheva, Yana
Novikov, Fedor
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[7] Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
Evgeny Bazdyrev
Maria Panova
Maria Brachs
Elena Smolyarchuk
Daria Tsygankova
Liudmila Gofman
Yana Abdyusheva
Fedor Novikov
Journal of Translational Medicine, 20
[8] Nitazoxanide in Patients Hospitalized With COVID-19 Pneumonia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
Rocco, Patricia R. M.
Silva, Pedro L.
Cruz, Fernanda F.
Tierno, Paulo F. G. M. M.
Rabello, Eucir
Junior, Jefiton Cordeiro
Haag, Firmino
de avila, Renata E.
da Silva, Joana D. G.
Mamede, Mariana M. S.
Buchele, Konrad S.
Barbosa, Luiz C. V.
Cabral, Anna C.
Junqueira, Antonio A. F.
Araujo-Filho, Joao A.
da Costa, Lucianna A. T. J.
Alvarenga, Pedro P. M.
Moura, Alexandre S.
Carajeleascow, Ricardo
de Oliveira, Mirella C.
Silva, Roberta G. F.
Soares, Cynthia R. P.
Fernandes, Ana Paula S. M.
Fonseca, Flavio Guimaraes
Camargos, Vidyleison Neves
Reis, Julia de Souza
Franchini, Kleber G.
Luiz, Ronir R.
Morais, Sirlei
Sverdloff, Carlos
Martins, Camila Marinelli
Felix, Nathane S.
Mattos-Silva, Paula
Nogueira, Caroline M. B.
Caldeira, Dayene A. F.
Pelosi, Paolo
Lapa-e-Silva, Jose R.
FRONTIERS IN MEDICINE, 2022, 9
[9] Efficacy of amantadine in patients hospitalized with COVID-19: Study protocol of a randomized, double-blind, placebo-controlled trial
Lopiano, Leonardo
Artusi, Carlo Alberto
Bozzali, Marco
Ancidoni, Antonio
Ciccone, Giovannino
De Rosa, Francesco
Vanacore, Nicola
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
[10] Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial
Leila N. Atmowihardjo
Job R. Schippers
Erik Duijvelaar
Imke H. Bartelink
Pierre M. Bet
Noortje E. L. Swart
Nienke van Rein
Keith Purdy
David Cavalla
Andrew McElroy
Sarah Fritchley
Anton Vonk Noordegraaf
Henrik Endeman
Patricia van Velzen
Matty Koopmans
Harm Jan Bogaard
Leo Heunks
Nicole Juffermans
Marcus J. Schultz
Pieter R. Tuinman
Lieuwe D. J. Bos
Jurjan Aman
Critical Care, 27

← 1 2 3 4 5 →